D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.24 MYR -1.59%
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Cash Flow Statement

Cash Flow Statement
Duopharma Biotech Bhd

Rotate your device to view
Cash Flow Statement
Currency: MYR
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
42
47
48
46
46
48
46
45
41
31
33
39
45
52
54
53
55
60
65
71
75
71
70
71
70
76
82
82
86
83
86
88
87
85
86
82
72
63
55
61
70
Depreciation & Amortization
8
8
8
9
18
22
25
27
22
23
22
23
25
24
24
24
22
25
25
25
26
27
28
29
30
29
30
31
32
32
33
33
33
36
37
38
40
43
45
47
48
Other Non-Cash Items
(0)
0
0
(0)
1
1
1
1
1
4
4
3
7
9
10
13
9
21
22
27
30
20
25
21
22
20
15
20
15
14
22
29
43
49
45
37
31
27
25
27
26
Cash Taxes Paid
8
10
10
9
8
13
12
14
15
13
14
15
15
12
9
7
5
7
11
14
17
19
19
20
21
18
14
10
7
12
14
17
21
25
24
26
25
17
17
14
10
Cash Interest Paid
0
0
0
1
2
4
5
6
6
6
5
0
7
5
7
8
6
8
9
11
10
9
8
7
8
6
6
6
6
12
13
12
14
17
18
22
24
22
24
26
27
Change in Working Capital
(23)
(19)
(8)
(114)
(119)
(121)
(132)
(17)
(14)
(25)
(34)
(45)
(38)
(29)
(53)
(42)
(39)
(33)
(35)
(36)
(65)
(51)
(26)
(24)
(11)
(54)
(67)
(75)
(126)
(86)
(78)
(101)
(76)
(99)
(140)
(124)
(106)
(85)
(55)
(82)
(50)
Cash from Operating Activities
27
N/A
36
+33%
49
+35%
(59)
N/A
(53)
+9%
(51)
+5%
(60)
-17%
56
N/A
50
-11%
33
-33%
25
-24%
20
-21%
38
+94%
56
+46%
34
-39%
49
+42%
48
-2%
72
+51%
78
+7%
87
+11%
66
-24%
67
+2%
96
+44%
97
+1%
110
+14%
71
-35%
59
-17%
58
-2%
7
-88%
43
+508%
63
+46%
50
-22%
87
+76%
70
-19%
29
-58%
33
+12%
36
+11%
49
+34%
70
+44%
53
-25%
94
+78%
Investing Cash Flow
Capital Expenditures
(10)
(12)
(14)
(17)
(30)
(41)
(39)
(41)
(32)
(35)
(47)
(48)
(67)
(75)
(78)
(80)
(83)
(93)
(84)
(92)
(72)
(61)
(62)
(60)
(66)
(66)
(80)
(108)
(124)
(115)
(112)
(83)
(66)
(71)
(61)
(50)
(46)
(40)
(30)
(32)
(29)
Other Items
0
0
2
(109)
142
(106)
(108)
4
(248)
4
0
4
4
3
3
(56)
(56)
(78)
0
(18)
(18)
1
0
25
4
4
0
(21)
0
(1)
(1)
2
1
2
2
2
(4)
(4)
(3)
(2)
6
Cash from Investing Activities
(10)
N/A
(12)
-17%
(12)
+2%
(126)
-956%
112
N/A
(147)
N/A
(147)
+0%
(38)
+74%
(279)
-641%
(30)
+89%
(43)
-40%
(43)
-2%
(63)
-45%
(72)
-14%
(76)
-5%
(136)
-80%
(140)
-2%
(170)
-22%
(162)
+5%
(110)
+32%
(90)
+18%
(59)
+34%
(60)
-1%
(35)
+42%
(61)
-78%
(61)
+0%
(76)
-23%
(130)
-72%
(124)
+5%
(116)
+6%
(113)
+3%
(81)
+28%
(65)
+21%
(70)
-8%
(59)
+15%
(48)
+18%
(51)
-5%
(43)
+15%
(32)
+25%
(34)
-5%
(23)
+32%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
253
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Issuance of Debt
4
(5)
10
245
104
104
104
(152)
(6)
(9)
4
2
(3)
14
23
88
108
114
95
56
38
21
24
12
(2)
35
46
65
141
97
97
73
17
26
13
17
163
116
93
88
(66)
Cash Paid for Dividends
(24)
(24)
(24)
(26)
(26)
(31)
(31)
(26)
(26)
(22)
0
(18)
(18)
(18)
0
0
(10)
(13)
0
0
(15)
(6)
0
0
(9)
(7)
0
(49)
(45)
(45)
0
(7)
(8)
(8)
0
(9)
(9)
(9)
(26)
(22)
(27)
Other
0
0
0
0
0
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
(20)
N/A
(24)
-20%
(24)
+0%
210
N/A
69
-67%
324
+372%
324
+0%
73
-77%
220
+199%
(32)
N/A
(18)
+43%
(16)
+10%
(21)
-30%
(4)
+81%
5
N/A
81
+1 413%
98
+21%
100
+3%
81
-19%
43
-47%
24
-45%
15
-36%
18
+20%
6
-65%
(10)
N/A
28
N/A
39
+40%
16
-58%
96
+490%
52
-45%
52
0%
66
+27%
9
-86%
18
+98%
5
-72%
8
+50%
154
+1 885%
108
-30%
67
-38%
66
-1%
(93)
N/A
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
(0)
0
(1)
(1)
(1)
(1)
0
0
0
0
1
0
1
1
(0)
0
(0)
(1)
(0)
(1)
(1)
(1)
(0)
0
1
1
0
1
(0)
1
1
0
(0)
(0)
(0)
(0)
1
1
Net Change in Cash
(4)
N/A
(1)
+84%
12
N/A
25
+97%
127
+418%
125
-1%
116
-7%
91
-22%
(10)
N/A
(29)
-174%
(36)
-24%
(40)
-12%
(46)
-15%
(19)
+59%
(36)
-91%
(6)
+84%
7
N/A
2
-69%
(3)
N/A
19
N/A
(2)
N/A
22
N/A
53
+135%
68
+28%
38
-44%
37
-1%
23
-40%
(55)
N/A
(20)
+63%
(20)
+1%
3
N/A
34
+952%
33
-5%
20
-40%
(25)
N/A
(8)
+67%
140
N/A
113
-19%
104
-7%
86
-18%
(21)
N/A
Free Cash Flow
Free Cash Flow
17
N/A
24
+35%
34
+46%
(76)
N/A
(84)
-10%
(92)
-10%
(99)
-7%
15
N/A
18
+23%
(1)
N/A
(22)
-1 399%
(28)
-29%
(29)
-4%
(19)
+36%
(44)
-137%
(31)
+29%
(35)
-14%
(20)
+42%
(7)
+66%
(5)
+24%
(6)
-18%
6
N/A
35
+471%
37
+7%
45
+20%
6
-87%
(21)
N/A
(51)
-146%
(117)
-132%
(72)
+39%
(49)
+32%
(34)
+32%
21
N/A
(1)
N/A
(32)
-4 106%
(17)
+45%
(10)
+44%
9
N/A
40
+334%
20
-50%
64
+219%

See Also

Discover More